Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
World Journal of Hepatology|February 21, 2017
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfectionKenneth E Sherman, Minhee Kang, Richard Sterling, et al.
Antiviral Research|September 16, 2017
Cell-line dependent antiviral activity of sofosbuvir against Zika virusNoreen Mumtaz, Leah C Jimmerson, Lane R Bushman, et al.
Pharmacotherapy|June 16, 2022
Cumulative tenofovir diphosphate exposure in persons with HIV taking single- vs. multiple-tablet regimensRyan P Coyle, Mary Morrow, Samantha MaWhinney, et al.
The Journal of Antimicrobial Chemotherapy|May 15, 2015
Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirinJoseph E Rower, Eric G Meissner, Leah C Jimmerson, et al.
Open Forum Infectious Diseases|September 29, 2021
Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIVJose R Castillo-Mancilla, Mary Morrow, Ryan P Coyle, et al.
Open Forum Infectious Diseases|October 19, 2020
Income Inequality Is Associated With Low Cumulative Antiretroviral Adherence in Persons With Human Immunodeficiency VirusFrances Vernon, Mary Morrow, Samantha MaWhinney, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 17, 2020
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS StudyJenna Yager, Jose Castillo-Mancilla, Mustafa E Ibrahim, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Small increase in dolutegravir trough, but equivalent total dolutegravir exposure with simeprevir in HIV/HCV seronegative volunteersChristine E MacBrayne, Jose Castillo-Mancilla, James R Burton, et al.
Pageof 10